<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00730626</url>
  </required_header>
  <id_info>
    <org_study_id>INAF-119</org_study_id>
    <nct_id>NCT00730626</nct_id>
  </id_info>
  <brief_title>Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health</brief_title>
  <acronym>PRO</acronym>
  <official_title>Dose Response Study of the Impact of a Yogurt Containing Bifidobacterium Lactis BB-12 and Lactobacillus Acidophilus LA-5 on the Immune System and Gut Health.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aliments ULTIMA Foods Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TransBiothec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the dose-response effect of a yogurt containing a
      combination of bifidobacterium Lactis (BB-12) and Lactobacillus Acidophilus (LA-5) and green
      tea extract on markers of the immune system and gut health in healthy subjects. We
      hypothesize that the response of the immune function will be dose-dependent of the probiotics
      found in the fermented yogurt.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is an increasing list of food containing probiotics on the market. Several studies have
      emphasized the health benefits of single probiotics, particularly on the immune system.
      However, it is unclear how a combination of two different probiotics complemented with green
      tea extract can beneficially modify markers of the immune.

      The aim of this study is to determine the dose-response effect of a yogurt containing a
      combination of bifidobacterium lactis (BB-12) and Lactobacillus Acidophilus LA-5 and green
      tea extract on immune system in healthy subjects. More specifically, this randomized,
      parallel placebo controlled study will investigate the impact of increasing doses (109 and
      1010) of these probiotics on phagocytosis activity, oxidative metabolism and on the
      antipneumococcics antibody specific serotype response S. pneumoniae vaccination. Finally,
      this study will also examine the effect of increasing dose of these probiotics on intestinal
      microflora and blood lipids.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phagocytosis activity and oxidative metabolism in phagocytes.</measure>
    <time_frame>6 weeks after vaccination</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>antipneumococcics antibody specific serotype response to S. pneumoniae vaccination.</measure>
    <time_frame>6 weeks after yogurt consumption and vaccination</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal microflora characteristics.</measure>
    <time_frame>4 weeks after yogurt consumption</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of blood lipids.</measure>
    <time_frame>After 4 weeks and 10 weeks of yogurt consumption</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Immune System</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>L.acidophilus and B.lactis (1x10E9 of each probiotics) with 40 mg of green the extract</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>L.acidophilus and B.lactis (1x 10E10 of each probiotics) with 40 mg of green tea extract</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Yogurt with 1X10E9 BB-12 and LA-5</intervention_name>
    <description>100g of yogurt containing the probiotics L.acidophilus and B.lactis (concentrations of 1x10E9 of each probiotics) with 40 mg of green tea extract, once a day for 10 weeks.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Yogurt with 1X10E10 BB-12 and LA-5</intervention_name>
    <description>100g of yogurt containing the probiotics L.acidophilus and B.lactis (concentrations of 1x10E10 of each probiotics) with 40 mg of green tea extract, once a day for 10 weeks.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Yogurt Placebo</intervention_name>
    <description>100g of yogurt placebo containing no probiotics and no green tea extract, once a day for 10 weeks.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 to 55 years

          -  Healthy individuals, non-smokers

          -  BMI between 18 and 35 kg/m2

          -  Stable weight (+/- 5kg) for 3 months before randomisation

          -  Agree to receive a vaccine Pneumovax 23®

        Exclusion Criteria:

          -  Pregnant or lactating woman

          -  Previous history of cardiovascular disease

          -  Diabetes

          -  Kidney or liver disease

          -  Gastrointestinal disorders or diseases

          -  Endocrine disorders or diseases

          -  Allergy

          -  Subjects taking hypolipidemic drugs, antidepressant, medication for high blood
             pressure, for inflammation or auto-immune diseases.

          -  Subject who have receive antipneumococcics vaccine in the year before randomisation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benoît Lamarche, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Nutraceuticals and Functional Foods (INAF), Laval University.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques Hébert, MD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Medicine, Laval University.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Nutraceuticals and Functional Foods (INAF), Laval University</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Winkler P, de Vrese M, Laue Ch, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther. 2005 Jul;43(7):318-26.</citation>
    <PMID>16035374</PMID>
  </reference>
  <reference>
    <citation>de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006 Nov 10;24(44-46):6670-4. Epub 2006 Jun 6.</citation>
    <PMID>16844267</PMID>
  </reference>
  <reference>
    <citation>Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol. 2006 Sep;17(6):416-21.</citation>
    <PMID>16925686</PMID>
  </reference>
  <reference>
    <citation>Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy. 2006 Oct;36(10):1227-35.</citation>
    <PMID>17014429</PMID>
  </reference>
  <reference>
    <citation>Olivares M, Díaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonollá J, Navas M, Rodríguez JM, Xaus J. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition. 2007 Mar;23(3):254-60.</citation>
    <PMID>17352961</PMID>
  </reference>
  <reference>
    <citation>Schiffrin EJ, Brassart D, Servin AL, Rochat F, Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr. 1997 Aug;66(2):515S-520S.</citation>
    <PMID>9250141</PMID>
  </reference>
  <reference>
    <citation>Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7.</citation>
    <PMID>10713750</PMID>
  </reference>
  <reference>
    <citation>Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001 Dec;74(6):833-9.</citation>
    <PMID>11722966</PMID>
  </reference>
  <reference>
    <citation>Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr. 2007 Apr;97(4):676-84.</citation>
    <PMID>17349080</PMID>
  </reference>
  <reference>
    <citation>Olivares M, Díaz-Ropero MP, Gómez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martín R, Rodríguez JM, Xaus J. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol. 2006 Mar;9(1):47-52.</citation>
    <PMID>16636989</PMID>
  </reference>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2008</study_first_submitted>
  <study_first_submitted_qc>August 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2008</study_first_posted>
  <last_update_submitted>June 19, 2009</last_update_submitted>
  <last_update_submitted_qc>June 19, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2009</last_update_posted>
  <responsible_party>
    <name_title>Benoît Lamarche, Study Principal Investigator</name_title>
    <organization>Institute of Nutraceuticals and Functional Foods (INAF), Laval University</organization>
  </responsible_party>
  <keyword>Probiotics</keyword>
  <keyword>Immunity</keyword>
  <keyword>Immune response</keyword>
  <keyword>Intestinal microflora</keyword>
  <keyword>Blood lipids</keyword>
  <keyword>Phagocytosis activity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

